✦ LIBER ✦

Healthcare Use and Costs of Medium-chain Acyl-Coa Dehydrogenase Deficiency in Australia: Screening Versus No Screening

✍ Scribed by Marion Haas; Meredyth Chaplin; Pamela Joy; Veronica Wiley; Carly Black; Bridget Wilcken

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of neonatal screening for medium

✍ Bridget Wilcken; Marion Haas; Pamela Joy; Veronica Wiley; Meredyth Chaplin; Carl 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 109 KB

Cost-effectiveness analysis of universal

✍ Hamers, Françoise F; Rumeau-Pichon, Catherine 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 407 KB

Is genotyping useful for the screening o

✍ C. Ged; H. Sebai; H. Verneuil; F. Parrot-Rouleau 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 231 KB

Clinical efficacy and cost-effectiveness

✍ Khai Tran; Srabani Banerjee; Huimin Li; Hussein Z. Noorani; Shaila Mensinkai; Ke 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Cost-Effectiveness of Neonatal Screening

✍ Christian S. van der Hilst; Terry G.J. Derks; Dirk-Jan Reijngoud; G. Peter A. Sm 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Newborn screening for medium-chain acyl-

✍ Maria Luz Couce, Paula Sánchez-Pintos, Luisa Diogo… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 184 KB